Agarose - BioChemika, for molecular biology
Navigation Links
Agarose - BioChemika, for molecular biology
| Products | Agarose - BioChemika, for molecular biology |
| Company | Sigma-Aldrich |
| Item | Agarose - BioChemika, for molecular biology |
| Features | |
| Description | Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis test in accordance |
| Info | Sigma-Aldrich Customer Service: (800) 521-8956 Web site: http://www.sigmaaldrich.com/Area_of_Interest/The_Americas/United_States.html |
Related medicine products :
1. LB Top Agarose 100ml Bottle
2. LB Agarose Plates
3. Agarose-HR™
4. Agarose for the Separation of GeneAmp® PCR Products
5. Certified PCR Agarose
6. Certified Molecular Biology Agarose
7. Certified Low Range Ultra Agarose
8. Certified Megabase Agarose
9. Agarose, Type C
10. SeaKem® GTG® Agarose
11. Agarose, separation > 500 bp, Genetic Performance Certified †
Breaking Medicine News(10 mins):Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 2Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 3Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 4Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 5Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2Health News:People affected by autism believe increase is 'real,' not diagnostic 2
[0] Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year[0] NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy[0] AIUM gears up for 2010 Annual Convention in San Diego, Calif.[0] People affected by autism believe increase is 'real,' not diagnostic[0] 5,000 deaths: A catastrophic, regrettable decision in Belgium
Other Medicine News:Health News:Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008 2Health News:Health groups issue updated colorectal cancer screening guidelines 2Health News:Health groups issue updated colorectal cancer screening guidelines 3Health News:New technique takes a big step in examination of small structures 2Health News:New technique takes a big step in examination of small structures 3Health News:New technique takes a big step in examination of small structures 4Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 3Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:New revelations in epigenetic control shed light on breast cancer 2
Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008Health groups issue updated colorectal cancer screening guidelinesNew technique takes a big step in examination of small structuresParker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent OmniscanCommunity & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating WorkersNew revelations in epigenetic control shed light on breast cancer
Breaking Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 1Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 3Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 1Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 2Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 3Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 1Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 2Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 3Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |